DHS | GenomeWeb

DHS

NEW YORK (GenomeWeb) — PositiveID and Ensco have been awarded a SenseNet Program contract for an undisclosed amount from the US Department of the Interior on behalf of the US Department of Homeland Security Science and Technology Directorate, Positive ID said today.

NEW YORK (GenomeWeb News) – OpGen today announced a collaboration with In-Q-Tel to develop a high-throughput sequence and genome mapping pipeline for microbial genome analysis.

Quanterix said this week that it has received an investment of an undisclosed amount from In-Q-Tel, a non-profit investment firm that delivers technology to the US intelligence community.

Idaho Technology said this week that its Razor EX BioThreat Detection System has received approval and certification as an AOAC performance-tested method for detecting Bacillus anthracis spores collected from the air on filter or liquid matrices.

Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.

The company will use the funds primarily to increase the sensitivity of its Pincer protein detection assay and to complete development of a six-protein biomarker panel for cardiovascular disease, said a company official.

The firm's device utilizes SNP chips to verify identity and kinship.

The legislation would protect companies that either base their corporate headquarters in Georgia, employ over 200 workers in manufacturing or research and development in the state, or have their principal place of research and development in Georgia.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.